Burning Rock Biotech (BNR) has released an update.
Burning Rock Biotech Limited has announced that it is now in compliance with NASDAQ’s minimum bid price requirement after its share restructuring, which adjusted the ratio of its American depositary shares. The company successfully maintained a minimum closing bid price of $1.00 per share for over 10 consecutive business days. This achievement signifies the company’s regained stability and adherence to NASDAQ’s stringent listing standards.
For further insights into BNR stock, check out TipRanks’ Stock Analysis page.
